Real-World Evidence on Second-Line Treatment of Metastatic Colorectal Cancer Using Fluoropyrimidine, Irinotecan, and Angiogenesis Inhibitor.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical colorectal cancer"
DOI: 10.1016/j.clcc.2021.03.001
Abstract: BACKGROUND Combination therapy comprised of fluoropyrimidine plus irinotecan with an angiogenesis inhibitor is widely used as a second-line treatment for metastatic colorectal cancer (mCRC). PATIENTS AND METHODS This retrospective study evaluated the efficacy and safety… read more here.
Keywords: plus bev; colorectal cancer; treatment; folfiri plus ... See more keywords